immunoglobulin
molecul
complex
structur
four
polypeptid
chain
organ
homodim
heterodim
compris
heavi
light
chain
proteolyt
enzym
papain
cleav
molecul
two
ident
fab
fragment
antigen
bind
fragment
one
fc
fragment
crystal
fragment
sinc
enzym
cut
hing
disulfid
bond
heavi
chain
thu
fab
fragment
compos
light
chain
consist
variabl
region
vl
constant
region
cl
fd
region
heavi
chain
contain
variabl
region
vh
constant
region
domain
form
two
variabl
region
bind
epitop
specif
antigen
sever
method
prepar
human
monoclon
polyclon
antibodi
develop
advanc
molecular
biolog
goal
therapeut
use
antibodi
hoet
et
al
kuroiwa
et
al
mendez
et
al
tomizuka
et
al
applic
phage
display
system
smith
effect
method
express
huge
repertoir
immunoglobulin
gene
barba
et
al
thie
et
al
use
system
valuabl
fab
fragment
select
gene
librari
barba
et
al
burton
et
al
method
protocol
phage
display
describ
detail
review
book
barba
et
al
antibodi
fv
fragment
compos
variabl
region
vhvl
especi
singl
chain
fv
scfv
also
prepar
use
phage
display
technolog
bird
et
al
frequent
use
better
toler
express
bacteria
comparison
fab
fragment
mondon
et
al
howev
fab
fragment
stabl
scfv
due
associ
cl
region
chapter
describ
product
recombin
human
fab
fragment
escherichia
coli
addit
phage
display
follow
screen
use
pan
method
allow
bypass
pan
process
introduc
phagemidbas
system
commonli
use
among
varieti
phage
display
system
phagemid
contain
origin
replic
e
coli
filament
phage
fl
fd
group
virus
infect
e
coli
mead
kemper
phage
particl
consist
singlestrand
dna
ssdna
genom
phage
surfac
copi
phage
coat
piii
involv
host
cell
recognit
infect
major
coat
protein
phage
coat
pviii
cover
length
particl
approxim
copi
contribut
structur
stabil
phage
particl
russel
thu
phagemid
combin
characterist
plasmid
antibiot
resist
facilit
replic
doublestrand
dna
dsdna
phage
product
packag
ssdna
phage
particl
light
chain
fd
region
gene
clone
appropri
site
secret
signal
sequenc
eg
pelb
ompa
phoa
coupl
gene
allow
secret
fd
light
chain
fragment
periplasm
fraction
e
coli
fab
fragment
fuse
piii
ctermin
domain
allow
display
phage
surfac
recombin
phagemid
introduc
compet
e
coli
electropor
fig
transform
effici
critic
direct
influenc
librari
size
therefor
electrocompet
cell
better
normal
compet
cell
transform
e
coli
superinfect
helper
phage
eg
vc
give
whole
phage
particl
helper
phage
slightli
defect
origin
replic
phagemid
dna
dominantli
packag
phage
particl
synthes
fd
light
chain
fragment
transport
periplasm
ss
bond
form
fragment
reduc
environ
fab
fragment
fuse
piii
display
phage
surfac
concomit
wildtyp
piii
provid
helper
phage
result
recombin
phage
infect
e
coli
phagemid
util
pviii
fab
fusion
protein
howev
high
valenc
display
librari
gener
lead
low
affin
fab
fragment
due
avid
effect
fabpiii
fusion
protein
may
toxic
cell
result
gene
delet
plasmid
instabl
stringent
control
fusion
protein
express
propag
step
critic
gener
lac
promot
use
drive
gene
express
phagemid
vector
thu
accommod
leaki
express
need
glucos
ad
lac
repressor
overexpress
elev
metabol
activatorregul
repress
robust
termin
upstream
lac
promot
also
reduc
background
express
krebber
et
al
tet
promot
tetracyclin
induc
promot
use
altern
approach
zahn
et
al
promot
gene
express
tightli
repress
absenc
induc
doxycyclin
tetracyclin
phage
display
system
connect
genotyp
antibodi
gene
packag
phage
particl
phenotyp
fab
surfac
phage
particl
affin
select
biopan
need
isol
fab
fragment
rang
antigen
immunoglobulin
gene
encod
fab
fragment
isol
immun
immun
librari
nonimmun
librari
donor
immun
librari
suitabl
gener
fab
fragment
target
high
affin
specif
sourc
immunoglobulin
gene
may
bone
marrow
spleen
tonsil
peripher
blood
lymphocyt
pbl
bone
marrow
ideal
sourc
difficult
obtain
pbl
commonli
use
onestep
rtpcr
enabl
construct
librari
suffici
amount
heavi
lightchain
gene
use
pair
fab
specif
primer
librari
construct
igm
mrna
b
cell
taken
nonimmun
donor
antibodi
librari
gener
show
weaker
affin
librari
size
larger
chanc
obtain
specif
antibodi
affin
target
increas
de
haard
et
al
larg
librari
construct
combin
heavi
light
chain
gene
clone
individu
librari
semisynthet
librari
use
merg
natur
synthet
divers
exampl
vh
region
librari
creat
semisynthet
complementar
determin
region
cdr
natur
donor
autoimmun
diseas
normal
donor
hoet
et
al
synthet
librari
compos
oligonucleotidederiv
cdr
heavi
light
chain
divers
almost
obtain
natur
roth
et
al
shi
et
al
affin
pm
shown
fab
fragment
librari
semisynthet
synthet
librari
commerci
avail
select
phage
fab
fragment
reactiv
antigen
perform
pan
fig
phage
particl
present
fab
fragment
incub
immobil
antigen
choic
elisa
plate
immunotub
kang
et
al
mark
et
al
nonbind
phage
remov
wash
phage
bind
antigen
elut
chang
bind
condit
eg
ph
chang
competit
elut
amplifi
reinfect
e
coli
cell
amplifi
phage
subject
round
pan
gradual
increas
frequenc
intens
wash
condit
pan
process
combin
posit
select
affin
specif
neg
select
toxic
bacteri
cell
tendenc
delet
unnecessari
dna
select
round
may
prefer
recov
fab
tightli
bind
antigen
proteolyt
enzym
digest
use
cut
proteas
site
fab
piii
ward
et
al
membran
protein
difficult
produc
solubl
form
protein
fold
critic
obtain
epitop
conform
cell
display
antigen
protein
produc
mammalian
cell
display
cell
surfac
case
antigenneg
cell
use
absorb
cell
bind
fab
fragment
absorb
cell
work
remov
sticki
clone
de
kruif
et
al
cell
sort
enabl
antigenspecif
fab
enrich
siegel
et
al
yeast
saccharomys
cerevisia
also
use
cell
display
platform
van
den
beucken
et
al
transform
effici
high
fab
librari
size
limit
ribosom
display
develop
expand
librari
size
hane
et
al
hudson
souriau
antibodi
limit
scfv
rather
fab
fragment
bypass
phage
display
pan
possibl
immunoglobulin
gene
librari
construct
pbl
immun
patient
posit
serolog
coloni
blot
screen
rel
old
approach
purpos
helfman
et
al
princip
method
shown
fig
plasmid
vector
use
prepar
combinatori
immunoglobulin
gene
librari
instead
use
phagemid
vector
size
librari
smaller
phage
display
librari
suffici
isol
fab
fragment
major
antigen
pathogen
number
bacteri
coloni
screen
use
filter
membran
also
limit
less
per
filter
fig
howev
shown
tabl
posit
rate
first
screen
coloni
blot
antigen
variou
pathogen
plasma
recov
isol
process
lymphocyt
peripher
blood
donor
use
detect
posit
clone
instead
use
monoclon
polyclon
antibodi
immun
anim
donor
antibodi
titer
target
antigen
suffici
cheng
et
al
antibodi
fraction
purifi
plasma
label
enzym
horseradish
peroxidas
use
detect
use
secondari
antibodi
specif
fc
region
human
igg
direct
bind
second
antibodi
human
fab
fragment
produc
e
coli
also
avoid
case
indirect
detect
liu
et
al
although
posit
first
screen
may
becom
neg
second
third
screen
use
elisa
indirect
immunofluorescein
antibodi
test
coloni
blot
simpl
effect
procedur
screen
human
fab
neutral
activ
pathogen
screen
coloni
blot
especi
suitabl
rel
small
librari
chainshuffl
librari
screen
bacteri
coloni
use
two
filter
membran
also
use
skerra
et
al
bacteria
secret
fab
fragment
periplasm
grown
membran
secret
fab
fragment
allow
diffus
second
membran
coat
antiglobulin
probe
antigen
bind
antigen
detect
second
membran
use
enzym
colloid
gold
conjug
posit
coloni
grown
first
membran
use
filter
membran
screen
also
applic
phageexpress
antibodi
librari
wu
et
al
method
pbl
collect
healthi
human
adult
volunt
high
antibodi
titer
target
antigen
pbl
infect
epsteinbarr
viru
ebv
strain
dose
transform
dose
ml
plate
plate
cell
per
well
fig
half
medium
chang
everi
day
cultur
continu
week
without
treatment
includ
singl
isol
process
ebvtransform
b
lymphoblastoid
cell
line
blcl
consist
sever
clone
establish
takekoshi
et
al
antibodi
titer
cultur
medium
check
antibodyproduc
cell
expand
dish
cell
medium
harvest
total
rna
extract
cell
immunoglobulin
gene
encod
fab
fragment
amplifi
rtpcr
clone
bacteri
express
vector
vector
transform
e
coli
coloni
pick
incub
express
fab
fragment
screen
clone
gener
suffici
obtain
posit
subsequ
assay
fab
fragment
elisa
ebvtransform
blcl
cultur
supernat
donor
found
reactiv
target
antigen
tabl
hamatak
et
al
tendenc
produc
autoantibodi
autoantibodi
titer
donor
normal
use
method
fab
fragment
human
cytomegaloviru
takekoshi
et
al
hepat
b
viru
santigen
maeda
et
al
human
tumor
necrosi
factoralpha
takekoshi
et
al
gangliosid
nagatsuka
et
al
human
hamatak
et
al
obtain
singl
isol
ebvtransform
lcl
frequent
caus
loss
mani
clone
may
make
difficult
isol
monoclon
antibodi
howev
oligoclon
blcl
immunoglobulin
gene
posit
clone
obtain
semiclon
level
low
risk
loss
clone
oligoclonallcl
stock
deep
freezer
long
period
gene
fab
fragment
rescu
rtpcr
even
loss
cell
viabil
fab
fragment
produc
periplasm
e
coli
express
recombin
fab
e
coli
vari
significantli
antibodi
antibodi
sever
limit
yield
fold
function
sometim
encount
bacteri
product
fab
fragment
express
efficaci
affect
vector
design
cultur
condit
temperatur
concentr
iptg
corisdeo
wang
shibui
nagahari
mani
case
success
express
shown
rel
low
temperatur
gentl
induct
low
iptg
concentr
amount
antibodi
express
also
depend
composit
poor
fab
express
link
poor
intrins
stabil
wherea
increas
fab
stabil
correl
higher
fab
yield
higher
level
properli
fold
function
protein
demarest
et
al
also
affect
growth
rate
e
coli
secret
fab
fragment
medium
limit
protein
express
may
overcom
singl
amino
acid
substitut
knappik
pluckthun
storag
fragment
periplasm
space
requir
break
outer
membran
bacteria
releas
fragment
selisko
et
al
takekoshi
et
al
fab
fragment
easili
purifi
cultur
medium
extract
fraction
bacteria
tag
histag
ad
clone
process
skerra
tachibana
et
al
express
level
light
chain
sometim
higher
fd
chain
light
chain
also
natur
tendenc
form
homodim
wherea
fd
fragment
usual
dimer
therefor
attach
histag
cterminu
fd
region
use
avoid
contamin
purifi
fraction
light
chain
dimer
system
function
heterodim
purifi
affin
chromatographi
use
antihuman
fab
antihuman
f
ab
antibodi
also
use
purif
fab
fragment
cheng
et
al
takekoshi
et
al
human
immun
system
affin
antibodi
matur
stepwis
fashion
incorpor
somat
hypermut
select
variant
increas
select
pressur
variou
vitro
strategi
use
matur
affin
recombin
fab
fragment
hoogenboom
includ
chain
shuffl
cdr
shuffl
sitedirect
random
mutagenesi
sitespecif
mutagenesi
use
modif
base
structur
inform
wherea
random
mutagenesi
includ
use
errorpron
pcr
gram
et
al
shuffl
light
heavi
chain
gene
effect
find
better
combin
heavi
light
chain
combinatori
librari
hur
et
al
lou
et
al
zhu
et
al
light
chain
gene
shuffl
posit
rate
coloni
blot
screen
higher
shuffl
analysi
heavi
chain
gene
tachibana
et
al
loss
partial
delet
clone
gene
chain
shuffl
also
use
find
complet
gene
fu
et
al
jia
et
al
residu
cdr
especi
heavi
light
chain
antibodi
thought
respons
highaffin
interact
antigen
therefor
increas
affin
may
occur
mutat
nativ
residu
exhibit
neg
effect
interact
howev
effect
mutat
restrict
contact
residu
winkler
et
al
instanc
light
chain
compris
amino
acid
kabat
number
system
johnson
wu
wu
kabat
although
residu
posit
may
interact
directli
antigen
molecul
affect
bind
residu
hall
et
al
thu
amino
acid
substitut
posit
may
result
conform
chang
allow
redistribut
neighbor
amino
acid
involv
antigenantibodi
interact
sitedirect
mutagenesi
recombin
pcr
high
fidel
dna
polymeras
feasibl
introduc
amino
acid
substitut
improv
affin
origin
human
fab
jone
winistorf
tachibana
et
al
framework
variabl
region
also
import
establish
correct
conform
cdr
loop
mutat
framework
may
affect
flexibl
cdr
loop
possibl
increas
affin
antibodi
fab
fragment
use
variou
procedur
increas
affin
may
correl
biolog
efficaci
howev
origin
antibodi
alreadi
demonstr
high
affin
threshold
effect
affin
matur
biolog
function
may
limit
hoogenboom
tachibana
et
al
phage
display
follow
pan
wide
use
prepar
recombin
antibodi
fab
fragment
larg
combinatori
immunoglobulin
gene
librari
immun
donor
shown
bypass
phage
display
pan
process
practic
immunoglobulin
gene
deriv
seroposit
donor
identif
bacteri
coloni
use
membran
filter
donor
plasma
use
initi
screen
human
fab
fragment
major
antigen
molecul
pathogen
prepar
immunoglobulin
gene
librari
eb
virustransform
oligoclon
blcl
also
use
prepar
human
fab
fragment
pathogen
selfantigen
recent
new
techniqu
bypass
phage
display
platform
also
develop
b
cell
cultur
near
clonal
densiti
cultur
supernat
screen
posit
use
clone
authent
antibodi
gene
walker
et
al
thu
improv
technolog
antibodi
engin
still
progress
gener
highaffin
human
antibodi
